Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Proteostasis Therapeutics Profit Margin 2014-2020 | PTI

Current and historical gross margin, operating margin and net profit margin for Proteostasis Therapeutics (PTI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Proteostasis Therapeutics net profit margin as of March 31, 2020 is 0%.
  
Proteostasis Therapeutics Annual Profit Margins
Proteostasis Therapeutics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.085B $0.005B
Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.197B 14.66
Gilead Sciences (GILD) United States $91.996B 11.93
CSL (CSLLY) Australia $87.164B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.883B 50.79
Regeneron Pharmaceuticals (REGN) United States $62.700B 24.17
Illumina (ILMN) United States $52.141B 53.58
Biogen (BIIB) United States $49.695B 8.51
Seattle Genetics (SGEN) United States $26.964B 0.00
Moderna (MRNA) United States $25.614B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.414B 9.63
Incyte (INCY) United States $21.600B 0.00
Genmab (GMAB) Denmark $19.127B 15.75
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Genmab (GNMSF) Denmark $17.896B 53.13
BioMarin Pharmaceutical (BMRN) United States $17.633B 159.85
Alnylam Pharmaceuticals (ALNY) United States $16.134B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.977B 38.43
Exact Sciences (EXAS) United States $12.517B 0.00
BeiGene (BGNE) Cayman Islands $12.307B 0.00
Sarepta Therapeutics (SRPT) United States $11.745B 0.00
BioNTech SE (BNTX) Germany $11.546B 0.00
Bio-Techne Corp (TECH) United States $10.183B 67.27
QIAGEN (QGEN) Netherlands $9.791B 28.47
Horizon Therapeutics Public (HZNP) Ireland $9.455B 23.27
Guardant Health (GH) United States $9.166B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.986B 0.00
Immunomedics (IMMU) United States $7.959B 0.00
Exelixis (EXEL) United States $7.550B 26.47
Repligen (RGEN) United States $7.297B 127.99
Ascendis Pharma (ASND) Denmark $7.032B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.759B 0.00
Reata Pharmaceuticals (RETA) United States $5.318B 0.00
Acceleron Pharma (XLRN) United States $5.307B 0.00
Adaptive Biotechnologies (ADPT) United States $5.295B 0.00
MyoKardia (MYOK) United States $5.018B 0.00
Mirati Therapeutics (MRTX) United States $4.435B 0.00
Emergent Biosolutions (EBS) United States $4.435B 29.07
Ultragenyx Pharmaceutical (RARE) United States $4.403B 0.00
MorphoSys AG (MOR) Germany $4.291B 33.29
CRISPR Therapeutics AG (CRSP) Switzerland $4.268B 93.25
China Biologic Products (CBPO) China $4.239B 23.57
Global Blood Therapeutics (GBT) United States $4.230B 0.00
Vir Biotechnology (VIR) United States $3.972B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.855B 0.00
Bluebird Bio (BLUE) United States $3.716B 0.00
Zai Lab (ZLAB) China $3.690B 0.00
Blueprint Medicines (BPMC) United States $3.532B 0.00
Halozyme Therapeutics (HALO) United States $3.341B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.309B 0.00
Amicus Therapeutics (FOLD) United States $3.267B 0.00
Viela Bio (VIE) United States $3.071B 0.00
NeoGenomics (NEO) United States $2.968B 216.77
Arena Pharmaceuticals (ARNA) United States $2.965B 0.00
UniQure (QURE) Netherlands $2.823B 0.00
Amarin (AMRN) Ireland $2.791B 0.00
Fate Therapeutics (FATE) United States $2.737B 0.00
Denali Therapeutics (DNLI) United States $2.688B 0.00
Alkermes (ALKS) Ireland $2.676B 52.69
Novavax (NVAX) United States $2.672B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.652B 0.00
Alector (ALEC) United States $2.616B 0.00
Insmed (INSM) United States $2.592B 0.00
Inovio Pharmaceuticals (INO) United States $2.226B 0.00
Principia Biopharma (PRNB) United States $2.148B 0.00
Epizyme (EPZM) United States $1.878B 0.00
Ligand Pharmaceuticals (LGND) United States $1.744B 67.90
Eidos Therapeutics (EIDX) United States $1.734B 0.00
Arvinas (ARVN) United States $1.724B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.707B 0.00
Editas Medicine (EDIT) United States $1.655B 0.00
Arcus Biosciences (RCUS) United States $1.648B 0.00
Zymeworks (ZYME) Canada $1.647B 0.00
Adverum Biotechnologies (ADVM) United States $1.644B 0.00
Sangamo Therapeutics (SGMO) United States $1.622B 0.00
REGENXBIO (RGNX) United States $1.618B 0.00
Twist Bioscience (TWST) United States $1.617B 0.00
Intra-Cellular Therapies (ITCI) United States $1.489B 0.00
Akcea Therapeutics (AKCA) United States $1.482B 0.00
Mesoblast (MESO) Australia $1.412B 0.00
PHARMA MAR SA (PHMMF) Spain $1.394B 0.00
NGM Biopharmaceuticals (NGM) United States $1.378B 0.00
Beam Therapeutics (BEAM) United States $1.319B 0.00
Cytokineticsorporated (CYTK) United States $1.303B 0.00
Zealand Pharma (ZEAL) Denmark $1.290B 0.00
I-Mab (IMAB) China $1.215B 0.00
Revance Therapeutics (RVNC) United States $1.212B 0.00
Coherus BioSciences (CHRS) United States $1.212B 8.46
Alcobra (ARCT) United States $1.159B 0.00
Myriad Genetics (MYGN) United States $1.098B 56.65
Intellia Therapeutics (NTLA) United States $1.078B 0.00
Sorrento Therapeutics (SRNE) United States $1.063B 0.00
Compugen (CGEN) Israel $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.939B 0.00
NextCure (NXTC) United States $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.907B 0.00
Cellectis S.A (CLLS) France $0.893B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Cue Biopharma (CUE) United States $0.856B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.773B 0.00
Cara Therapeutics (CARA) United States $0.770B 0.00
Heska (HSKA) United States $0.767B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.751B 0.00
Kadmon Holdings (KDMN) United States $0.746B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.733B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.724B 0.00
Retrophin (RTRX) United States $0.719B 0.00
Kala Pharmaceuticals (KALA) United States $0.714B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.700B 0.00
Codexis (CDXS) United States $0.662B 0.00
Castle Biosciences (CSTL) United States $0.653B 0.00
Vericel (VCEL) United States $0.643B 118.83
Morphic Holding (MORF) United States $0.640B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.625B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.620B 5.31
Bellus Health (BLU) Canada $0.620B 0.00
Frequency Therapeutics (FREQ) United States $0.612B 0.00
Athersys (ATHX) United States $0.601B 0.00
Mersana Therapeutics (MRSN) United States $0.584B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.578B 0.00
MeiraGTx Holdings (MGTX) United States $0.576B 0.00
VBI Vaccines (VBIV) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.555B 0.00
NantKwest (NK) United States $0.550B 0.00
AnaptysBio (ANAB) United States $0.542B 0.00
Clovis Oncology (CLVS) United States $0.539B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
UROGEN PHARMA (URGN) United States $0.531B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.521B 0.00
AC Immune SA (ACIU) Switzerland $0.503B 0.00
DBV Technologies S.A (DBVT) France $0.494B 0.00
BioDelivery Sciences (BDSI) United States $0.493B 25.97
Aquinox Pharmaceuticals (NLTX) United States $0.493B 0.00
Prothena (PRTA) Ireland $0.474B 0.00
Anika Therapeutics (ANIK) United States $0.474B 15.24
Dynavax Technologies (DVAX) United States $0.473B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.464B 0.00
Puma Biotechnology (PBYI) United States $0.461B 0.00
Merus (MRUS) Netherlands $0.440B 0.00
Intrexon (PGEN) United States $0.439B 0.00
Protagonist Therapeutics (PTGX) United States $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.430B 0.00
CytomX Therapeutics (CTMX) United States $0.426B 0.00
MiMedx (MDXG) United States $0.419B 0.00
Agenus (AGEN) United States $0.418B 0.00
Seres Therapeutics (MCRB) United States $0.401B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.396B 0.00
WAVE Life Sciences (WVE) Singapore $0.387B 0.00
PDL BioPharma (PDLI) United States $0.386B 331.00
Albireo Pharma (ALBO) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.382B 7.57
Kamada (KMDA) Israel $0.382B 15.89
Precision BioSciences (DTIL) United States $0.381B 0.00
Geron (GERN) United States $0.369B 0.00
Selecta Biosciences (SELB) United States $0.343B 0.00
MannKind (MNKD) United States $0.320B 0.00
Menlo Therapeutics (MNLO) United States $0.305B 0.00
Verastem (VSTM) United States $0.302B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.272B 0.00
Abeona Therapeutics (ABEO) United States $0.270B 0.00
Starpharma Holdings (SPHRY) Australia $0.268B 0.00
Aduro Biotech (ADRO) United States $0.263B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
Gritstone Oncology (GRTS) United States $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Exicure (XCUR) United States $0.241B 0.00
Liquidia Technologies (LQDA) United States $0.239B 0.00
XOMA (XOMA) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
OSMOTICA PHARM (OSMT) United States $0.230B 0.00
Northwest Biotherapeutics (NWBO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Affimed (AFMD) Germany $0.228B 0.00
HOOKIPA Pharma (HOOK) United States $0.224B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.215B 3.24
IVERIC Bio (ISEE) United States $0.213B 0.00
Pluristem Therapeutics (PSTI) Israel $0.209B 0.00
ARAVIVE, INC (ARAV) United States $0.204B 0.00
Kindred Biosciences (KIN) United States $0.201B 0.00
Strongbridge Biopharma (SBBP) United States $0.201B 0.00
Five Prime Therapeutics (FPRX) United States $0.199B 0.00
VTv Therapeutics (VTVT) United States $0.198B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.197B 0.00
Prometic Life Sciences (LMNL) Canada $0.195B 0.00
Aptinyx (APTX) United States $0.192B 0.00
Aytu Bioscience (AYTU) United States $0.182B 0.00
Dyadic (DYAI) United States $0.165B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.161B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.158B 0.00
Biofrontera AG (BFRA) Germany $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Antibe Therapeutics (ATBPF) Canada $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Trevena (TRVN) United States $0.144B 0.00
Cerecor (CERC) United States $0.142B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
AIT Therapeutics (XAIR) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.125B 0.00
Cyclerion Therapeutics (CYCN) United States $0.119B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Lumos Pharma (LUMO) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.107B 0.00
Eton Pharmaceuticals (ETON) United States $0.100B 0.00
Organovo Holdings (ONVO) United States $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.091B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.089B 0.00
Celsion (CLSN) United States $0.089B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Adocia (ADOCY) France $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Happiness Biotech Group (HAPP) China $0.070B 0.00
Oncobiologics (OTLK) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Apricus Biosciences (SEEL) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Advaxis (ADXS) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.036B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
Evogene (EVGN) Israel $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
TrovaGene (CRDF) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Bionano Genomics (BNGO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00